Infectious Diseases Experts Urge Increased Focus on Preventing Deadly Infections

Article

The Centers for Disease Control and Prevention (CDC) released new data today showing that recent declines in methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-susceptible Staphylococcus aureus (MSSA) have plateaued in many U.S. hospitals. The Society for Healthcare Epidemiology of America (SHEA) said the data demonstrates the need to focus on evidence-based interventions to prevent transmission, improve patient care, and reduce the risks associated with these deadly bacteria. 
 
"The report highlights the critical impact made by dedicated healthcare epidemiologists working with their hospital and health system partners to protect patients over the last decade.  It also shows that there is more work to be done,” said Hilary Babcock, MD, MPH, SHEA president.  “For MRSA and MSSA, no single prevention approach works in all situations. Combination, or bundled, interventions are usually the best approach. Which strategies will have the biggest impact may depend on the local context. SHEA urges expanded funding support for research into what interventions are most effective in what settings, so that infection prevention programs can continue to reduce these infections in patients across healthcare settings.” 
 
The prevention efforts outlined in the CDC’s Vital Signs report reflect the practice recommendations outlined five years ago by SHEA as a part of Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals: 2014 Update, a series of articles outlining evidence-based strategies to help healthcare personnel effectively control and prevent the spread of healthcare-associated infections (HAIs).  
 
These recommendations include: 
●    Conduct an MRSA risk assessment: Hospitals should focus on preventing opportunities for MRSA transmission and on estimating facility-specific MRSA burden and rates of transmission and infection.
●    Implement a MRSA monitoring program and track rates: the program should focus on identifying any patient with a current or prior history of MRSA and provide mechanisms for tracking hospital-onset cases of infection. Alerts should be sent from the laboratory to notify healthcare personnel of patients with MRSA.
●    Ensure compliance with hand hygiene recommendations: Healthcare personnel should perform hand hygiene in accordance with CDC or World Health Organization recommendations.
●    Ensure proper cleaning and disinfection of equipment and the environment: Because contamination can be widespread within a patient's environment, optimal cleaning and disinfection procedures should be employed.
●    Educate healthcare personnel, patients, and families about MRSA: Personnel, patients, and families should be made aware of risk and their role in prevention, transmission, and compliance with recommended precautions.
●    Implement an alert system: Hospitals should have a notification system for patients with laboratory-identified MRSA or those readmitted with MRSA to provide timely information and allow prompt initiation of control measures.
 
SHEA encourages investment into sound scientific research studies on how MRSA and MSSA spreads and on effective prevention efforts using novel strategies.

The report highlights the significant improvements in patient protection from Staph infections that have resulted from dedicated healthcare epidemiologists working with their hospital and healthcare system partners over the last decades.  

Source: SHEA
 

Recent Videos
Meet Alexander Sundermann, DrPH, CIC, FAPIC.
Veterinary Infection Prevention
Andreea Capilna, MD, PhD
Meet the Infection Control Today Editorial Advisory Board Members: Priya Pandya-Orozco, DNP, MSN, RN, PHN, CIC.
Meet Infection Control Today's Editorial Board Member: Tommy Davis, PhD, ACHE, APIC, BLS
Fungal Disease Awareness Week
Meet Shannon Simmons, DHSc, MPH, CIC.
Meet Matthew Pullen, MD.
Clostridioides difficile  (Adobe Stock 260659307 by gaetan)
Related Content